Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: E_K_S who wrote (62125)	6/12/2019 3:31:34 PM
From: Lazarus	Respond to of 78744

Thanks - put them both on watch.

To: E_K_S who wrote (62125)	8/9/2019 8:53:57 AM
From: E_K_S	Respond to of 78744

Hopefully, this will translate into huge license/royalty revenues but it take a long time from development to getting seed in the ground. Company continues to burn cash but did a private secondary offering around $4/share. Arcadia Bio up 60% premarket on USDA OK of drought-tolerant soybean strain Aug. 9, 2019 8:34 AM ET\|About: Arcadia Biosciences, Inc. (RKDA)\|By: Douglas W. House, SA News Editor Thinly traded nano cap Arcadia Biosciences (NASDAQ: RKDA) is up 60% premarket on robust volume in reaction to its announcement that the USDA has approved Verdeca's HB4 drought-tolerant soybeans, clearing the way for commercialization in the U.S. (the FDA signed off on HB4 two years ago). HB4 now has regulatory approval in more than 80% of the world soybean market. Verdeca is the joint venture between Arcadia and Bioceres Crop Solutions (NYSEMKT: BIOX).